Drug Type Monoclonal antibody |
Synonyms Anti-CD4 monoclonal antibody IDEC-CE9.1, PRIMATIZED anti-CD4 antibody IDEC-CE9.1, CE9.1 + [3] |
Target |
Action inhibitors |
Mechanism CD4 inhibitors(T-cell surface antigen CD4 inhibitors) |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization |
Drug Highest PhaseDiscontinuedPhase 3 |
First Approval Date- |
Regulation- |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | Keliximab | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Asthma | Phase 3 | United States | - | - |
Asthma | Phase 3 | - | - | |
Asthma | Phase 3 | - | - | |
Rheumatoid Arthritis | Phase 3 | United States | - | - |
Rheumatoid Arthritis | Phase 3 | - | - |